A new inhaled antibiotic for the treatment of cystic fibrosis called Cayston® is now available for patients through select specialty pharmacies, including the CF Services Pharmacy.
Site Search
Showing 91 - 100 of 790 results
News
|
Dec. 28, 2007
|
1 min read
News
|
Aug. 11, 2014
|
1 min read
News
|
March 19, 2007
|
2 min read
News
|
June 16, 2010
|
2 min read
News
|
Nov. 21, 2007
|
2 min read
News
|
March 4, 2010
|
2 min read
A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.
News
|
Nov. 15, 2010
|
2 min read
The 24th annual Ultimate Golf Experience brought together a standout array of entertainers, guests, and friends of the Cystic Fibrosis Foundation for a premier golfing event to raise funds in the fight against cystic fibrosis.
News
|
Dec. 4, 2018
|
3 min read
The U.S. Food and Drug Administration approved the use of lumacaftor/ivacaftor (Orkambi®) today for children with cystic fibrosis ages 2 to 5 who have two copies of the F508del mutation.
News
|
Aug. 7, 2018
|
3 min read
Check in with your cystic fibrosis care team several months before your trip.
6 min read